Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life

Vaccine

Volumn 25, Issue 8, 2007, Pages 1509-1512

  van der Sande, M A B ^a   Mendy, M ^a   Waight, P ^a   Doherty, C ^a   McConkey, S J ^a   Hall, A J ^b   Whittle, H C ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cohort; Dosing; Hepatitis B; The Gambia; Vaccine efficacy

Indexed keywords

HEPACINE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; FEMALE; FOLLOW UP; GAMBIA; HEPATITIS B; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; INFANT; INFANT, NEWBORN; MALE; VACCINATION;

EID: 33846227829     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.023     Document Type: Article

References (17)

1. Wilson J.N., and Nokes D.J. Do we need 3 doses of hepatitis B vaccine?. Vaccine 17 (1999) 2667-2673
2. Jilg W., Schmidt M., and Deinhardt F. Immune response to hepatitis B revaccination. J Med Virol 24 (1988) 377-384
3. Gellin B.G., Greenberg R.N., Hart R.H., Bertino J.S., Stein D.H., Deloria M.A., et al. Immunogenicity of two doses of yeast recombinant hepatitis B vaccine in healthy older adults. J Infect Dis 175 (1997) 1494-1497
4. Marsano L.S., West D.J., Chan I., Hesley T.M., Cox J., Hackworth V., et al. A two-dose hepatitis B vaccine regimen: proof of priming and memory responses in young adults. Vaccine 16 (1998) 624-629
5. Wistrom J., Ahlm C., Lundberg S., Settergren B., and Tarnvik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 17 (1999) 2162-2165
6. Levie K., Gjorup I., Skinhoj P., and Stoffel M. A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults. Scand J Infect Dis 34 (2002) 610-614
7. Cassidy W.M., Watson B., Ioli V.A., Williams K., Bird S., and West D.J. A randomised trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunological memory. Pediatrics 107 (2001) 626-631
8. Heron L.G., Chant K.G., and Jalaludin B.B. A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart. Vaccine 20 (2002) 3472-3476
9. Yuen M.F., Lim W.L., Cheng C.C., Lam S.K., and Lai C.L. Twelve-year follow-up of a prospective randomised trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children. Hepatology 29 (1999) 924-927
10. Tabor E., Cairns J., Gerety R.J., and Bayley A.C. Nine-year follow-up of a plasma-derived hepatitis B vaccine in a rural African setting. J Med Virol 40 (1993) 204-209
11. Akram S., Maqbool S., Khan D.S., Jafri R., Rondhawa S., Valenzula-Silva C., et al. Immunogenicity of a recombinant, yeast-derived, anti-hepatitis-B vaccine after alternative dosage and schedule vaccination in Pakistani children. Vaccine 23 (2005) 5792-5797
12. Whittle H.C., Inskip H., Hall A.J., Mendy M., Downes R., and Hoare S. Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia. Lancet 337 (1991) 747-750
13. van der Sande M.A.B., Waight P., Mendy M., Rayco-Solon P., Hutt P., Fulford T., et al. Long-term protection against carriage of hepatitis B after infant vaccination. J Infect Dis 193 (2006) 1528-1535
14. Whittle H., Inskip H., Bradley A.K., et al. The pattern of childhood hepatitis B infection in two Gambian villages. J Infect Dis 161 (1990) 1112-1115
15. Edmunds W.J., Medley G.F., Nokes D.J., Hall A.J., and Whittle H.C. The influence of age on the development of the hepatitis B carrier state. Proc R Soc Lond 253 (1993) 197-201
16. Froehlich H., and West D.J. Compliance with hepatitis B virus vaccination in a high-risk population. Ethn Dis 11 (2001) 548-553
17. European Consensus Group on Hepatitis B immunity. Are booster immunisations needed for lifelong hepatitis B immunity?. Lancet 355 (2000) 561-565